Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 30.31M | 31.91M | 33.34M | 32.80M | 31.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.31M | 31.91M | 33.34M | 32.80M | 31.76M |
| Cost of Revenue | 16.86M | 17.28M | 18.78M | 18.97M | 19.26M |
| Gross Profit | 13.46M | 14.63M | 14.56M | 13.83M | 12.51M |
| SG&A Expenses | 21.62M | 24.36M | 28.24M | 33.55M | 34.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.83M | 44.28M | 50.26M | 56.03M | 57.35M |
| Operating Income | -10.52M | -12.37M | -16.92M | -23.22M | -25.58M |
| Income Before Tax | -7.21M | -9.82M | -17.55M | -23.32M | -25.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.21 | -9.82 | -17.55 | -23.32 | -25.34 |
| Earnings from Discontinued Operations | -15.63M | -16.26M | 62.28M | 55.88M | 49.65M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.84M | -26.08M | 44.73M | 32.57M | 24.31M |
| EBIT | -10.52M | -12.37M | -16.92M | -23.22M | -25.58M |
| EBITDA | -9.19M | -11.10M | -15.44M | -21.43M | -23.43M |
| EPS Basic | -0.45 | -0.51 | 0.92 | 0.67 | 0.50 |
| Normalized Basic EPS | -0.09 | -0.12 | -0.22 | -0.29 | -0.32 |
| EPS Diluted | -0.45 | -0.51 | 0.92 | 0.67 | 0.50 |
| Normalized Diluted EPS | -0.09 | -0.12 | -0.22 | -0.29 | -0.32 |
| Average Basic Shares Outstanding | 204.85M | 202.79M | 201.05M | 199.22M | 197.46M |
| Average Diluted Shares Outstanding | 204.85M | 202.79M | 201.05M | 199.22M | 197.46M |
| Dividend Per Share | 0.10 | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
